Venetoclax targets BCL2 in chronic lymphocytic leukaemia
- PMID: 26687593
- DOI: 10.1016/S1470-2045(15)00576-8
Venetoclax targets BCL2 in chronic lymphocytic leukaemia
Comment on
-
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. Epub 2015 Dec 6. N Engl J Med. 2016. PMID: 26639348 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
